Journal article icon

Journal article

Study protocol: infectious diseases consortium (I3D) for study on integrated and innovative approaches for management of respiratory infections: respiratory infections research and outcome study (RESPIRO)

Abstract:
Background: Community-acquired respiratory infections are a leading cause of illness and death globally. The aetiologies of community-acquired pneumonia remain poorly defined. The RESPIRO study is an ongoing prospective observational cohort study aimed at developing pragmatic logistical and analytic platforms to accurately identify the causes of moderate-to-severe community-acquired pneumonia in adults and understand the factors influencing disease caused by individual pathogens. The study is currently underway in Singapore and has plans for expansion into the broader region. Methods: RESPIRO is being conducted at three major tertiary hospitals in Singapore. Adults hospitalised with acute community-acquired pneumonia or lower respiratory tract infections, based on established clinical, laboratory and radiological criteria, will be recruited. Over the course of the illness, clinical data and biological samples will be collected longitudinally and stored in a biorepository for future analysis. Discussion: The RESPIRO study is designed to be hypothesis generating, complementary to and easily integrated with other research projects and clinical trials. The detailed clinical database and biorepository will yield insights into the epidemiology and outcomes of community-acquired lower respiratory tract infections in Singapore and the surrounding region and offers the opportunity to deeply characterise the microbiology and immunopathology of community-acquired pneumonia.National Medical Research Council (NMRC)Published versionThis study is funded by the National Medical Research Council (NMRC) Open Fund Large Collaborative Grant (Award ID: OFLCG19May-0034). It has no role in the conceptualization, design, data collection, analysis, or decision to publish and in preparation of the manuscript
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1186/s12879-023-08795-8

Authors

More by this author
Role:
Author
ORCID:
0000-0003-0917-1474
More by this author
Role:
Author
ORCID:
0000-0003-1010-2230
More by this author
Role:
Author
ORCID:
0000-0002-8781-0713
More by this author
Role:
Author
ORCID:
0000-0003-4426-131X


More from this funder
Funder identifier:
10.13039/501100001349
Grant:
OFLCG19May-0034


Publisher:
BioMed Central
Journal:
BMC Infectious Diseases More from this journal
Volume:
24
Issue:
1
Pages:
123-123
Article number:
123
Publication date:
2024-01-23
DOI:
EISSN:
1471-2334
ISSN:
1471-2334


Language:
English
Keywords:
Pubs id:
1620542
Local pid:
pubs:1620542
Source identifiers:
W4391135306
Deposit date:
2026-06-08
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP